CD86 and COVID-19: We suspect that the ongoing, low-level, systemic inflammation from lung repair following COVID-19 (68) could be the cause of the increased CD86 on monocyte and DC populations since CD86 expression is elevated in chronic HIV-1 and HCV, both infections that cause inflammation (62–64).